DSCAM and breast cancer: Finally, overexpression of DSCAM-AS1 in T-47D and ZR-75.1 BC cell lines, which show lower expression level of the lncRNA compared to MCF-7 cells, confers a proliferative advantage and a pronounced migratory phenotype [10], suggesting a DSCAM-AS1 oncogenic role in BC progression.